165 related articles for article (PubMed ID: 11734670)
1. The reduced sensitivity of the ProC Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk.
Gemmati D; Serino ML; Tognazzo S; Ongaro A; Moratelli S; Gilli G; Forini E; De Mattei M; Scapoli GL
Blood Coagul Fibrinolysis; 2001 Dec; 12(8):691-7. PubMed ID: 11734670
[TBL] [Abstract][Full Text] [Related]
2. A modified functional global test to measure protein C, protein S activities and the activated protein C-resistance phenotype.
Gemmati D; Serino ML; Scapoli GL
Thromb Res; 1998 Nov; 92(3):141-8. PubMed ID: 9806366
[TBL] [Abstract][Full Text] [Related]
3. ProC global: a new automated screening assay for the evaluation of total function of the protein C system.
Dragoni F; Tormene D; Simioni P; Arcieri P; Avvisati G; Girolami A
Clin Appl Thromb Hemost; 2001 Oct; 7(4):351-5. PubMed ID: 11697723
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of the ProC global assay for protein C pathway abnormalities. clinical experience in 899 unselected patients with venous thromboembolism.
Toulon P; Adda R; Perez P
Thromb Res; 2001 Oct; 104(2):93-103. PubMed ID: 11672753
[TBL] [Abstract][Full Text] [Related]
5. Pro CR global: an effective screening test for thrombophilia.
Gupta PK; Ahmed R; Kannan M; Dwivedi SN; Choudhry VP; Saxena R
Am J Hematol; 2003 Nov; 74(3):208-10. PubMed ID: 14587054
[TBL] [Abstract][Full Text] [Related]
6. Laboratory diagnosis of hereditary thrombophilia.
Michiels JJ; Hamulyák K
Semin Thromb Hemost; 1998; 24(4):309-20. PubMed ID: 9763348
[TBL] [Abstract][Full Text] [Related]
7. [Clinical usefulness of global assays of the anticoagulant pathway of protein C].
Toulon P
Ann Biol Clin (Paris); 2001; 59(5):545-50. PubMed ID: 11602384
[TBL] [Abstract][Full Text] [Related]
8. Modification of the ProC Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation.
Quincampoix JC; Legarff M; Rittling C; Andiva S; Toulon P
Blood Coagul Fibrinolysis; 2001 Oct; 12(7):569-76. PubMed ID: 11685046
[TBL] [Abstract][Full Text] [Related]
9. ProC Global: the first functional screening assay for the complete protein C pathway.
Dati F; Hafner G; Erbes H; Prellwitz W; Kraus M; Niemann F; Noah M; Wagner C
Clin Chem; 1997 Sep; 43(9):1719-23. PubMed ID: 9299966
[TBL] [Abstract][Full Text] [Related]
10. Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation.
Toulon P; Halbmeyer WM; Hafner G; Schmitt Y; Randgard B; Odpadlik M; Van Den Eynden C; Wagner C
Blood Coagul Fibrinolysis; 2000 Jul; 11(5):447-54. PubMed ID: 10937806
[TBL] [Abstract][Full Text] [Related]
11. A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study.
Toulon P; Smirnov M; Triscott M; Safa O; Biguzzi E; Bouziane K; Tripodi A
Thromb Res; 2009 May; 124(1):137-43. PubMed ID: 19157524
[TBL] [Abstract][Full Text] [Related]
12. An abnormal ProC Global test result is associated with an increased risk of venous thromboembolism independent of test sensitivity for protein C pathway abnormalities.
Toulon P; Perez P; Rapp J; Adda R
Thromb Haemost; 2007 Jul; 98(1):228-33. PubMed ID: 17598017
[TBL] [Abstract][Full Text] [Related]
13. ProC Global assay in the evaluation of women with history of severe preeclampsia or HELLP syndrome.
Heilmann L; von Tempelhoff GF; Pollow K
Clin Appl Thromb Hemost; 2002 Oct; 8(4):319-24. PubMed ID: 12518722
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of screening tests for defects in the protein C pathway: commercial kits lack sensitivity and specificity.
Gardiner C; Cooper PC; Makris M; Mackie IJ; Malia RG; Machin SJ
Blood Coagul Fibrinolysis; 2002 Mar; 13(2):155-63. PubMed ID: 11914658
[TBL] [Abstract][Full Text] [Related]
15. Screening for risk factors for thrombosis using a new generation of assays developed to evaluate the functionality of the protein C anticoagulant pathway.
Toulon P; Perez P
Hematol Oncol Clin North Am; 2000 Apr; 14(2):379-89. PubMed ID: 10806561
[TBL] [Abstract][Full Text] [Related]
16. Protein C deficiency as the major cause of thrombophilias in childhood.
Ohga S; Ishiguro A; Takahashi Y; Shima M; Taki M; Kaneko M; Fukushima K; Kang D; Hara T;
Pediatr Int; 2013 Jun; 55(3):267-71. PubMed ID: 23521084
[TBL] [Abstract][Full Text] [Related]
17. Age-specific onset and distribution of the natural anticoagulant deficiency in pediatric thromboembolism.
Ichiyama M; Ohga S; Ochiai M; Tanaka K; Matsunaga Y; Kusuda T; Inoue H; Ishimura M; Takimoto T; Koga Y; Hotta T; Kang D; Hara T
Pediatr Res; 2016 Jan; 79(1-1):81-6. PubMed ID: 26372516
[TBL] [Abstract][Full Text] [Related]
18. "ProC Global": a functional screening test that predicts recurrent venous thromboembolism.
Grand'Maison A; Bates SM; Johnston M; McRae S; Ginsberg JS
Thromb Haemost; 2005 Mar; 93(3):600-4. PubMed ID: 15735816
[TBL] [Abstract][Full Text] [Related]
19. Resistance to activated protein C and low levels of protein S activity in nine thrombophilic families: a correct diagnosis.
Gemmati D; Serino ML; Verzola I; Mari R; Moratelli S; Ballerini G
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):118-23. PubMed ID: 9518043
[TBL] [Abstract][Full Text] [Related]
20. The Factor V (Leiden) test: evaluation of an assay based on dilute Russell Viper Venom Time for the detection of the Factor V Leiden mutation.
Quehenberger P; Handler S; Mannhalter C; Kyrle PA; Speiser W
Thromb Res; 1999 Oct; 96(2):125-33. PubMed ID: 10574590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]